Form 4 Tracker
BridgeBio Pharma, Inc.
BBIO

45 insider filings · Latest: Sep 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 26, 2025Jun 26 8:13 PMERICKA VON KAEPPLER & DENIS VON KAEPPLER JT TEN
Proposed Sale
398$44.13$17.6K—

View →

Jun 24, 2025Jun 24 9:59 PMMCCORMICK FRANK
Proposed Sale
100,000$44.23$4.4M—

View →

Jun 10, 2025Jun 10 8:01 PMHANNAH A VALANTINE
Proposed Sale
4,292$40.00$171.7K—

View →

May 19, 2025May 19 8:25 PMNEIL KUMAR
Proposed Sale
26,156$33.84$885.1K—

View →

May 12, 2025May 13 1:46 AMKKR Genetic Disorder L.P.
Proposed Sale
6,000,000$35.68$214.1M—

View →

May 2, 2025May 2 8:36 PMLo Andrew
Proposed Sale
100,000$35.23$3.5M—

View →

Apr 14, 2025Apr 14 8:21 PMANDREA ELLIS
Proposed Sale
10,000$35.00$350.0K—

View →

Apr 1, 2025Apr 2 8:48 PMANDREA ELLIS
Proposed Sale
30,000$34.05$1.0M—

View →

Mar 6, 2025Mar 6 9:06 PMHANNAH A VALANTINE
Proposed Sale
12,875$32.58$419.5K—

View →

Mar 5, 2025Mar 6 2:09 AMKKR Genetic Disorder L.P.
Proposed Sale
6,000,000$34.97$209.8M—

View →

Feb 25, 2025Feb 25 9:35 PMKUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018
Proposed Sale
300,000$36.25$10.9M—

View →

Feb 25, 2025Feb 25 9:34 PMBRIAN STEPHENSON
Proposed Sale
34,000$36.25$1.2M—

View →

Feb 19, 2025Feb 19 9:31 PMNEIL KUMAR
Proposed Sale
31,543$35.49$1.1M—

View →

Feb 19, 2025Feb 19 9:31 PMBRIAN STEPHENSON
Proposed Sale
4,148$35.49$147.2K—

View →

Jan 31, 2025Feb 1 12:18 AMVIKING GLOBAL INVESTORS LP
Proposed Sale
3,065,616$34.90$107.0M—

View →

Jan 28, 2025Jan 28 9:18 PMKUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018
Proposed Sale
600,000$36.67$22.0M—

View →

Jan 28, 2025Jan 28 9:18 PMBRIAN STEPHENSON
Proposed Sale
68,000$36.67$2.5M—

View →

Nov 19, 2024Nov 19 9:28 PMBRIAN STEPHENSON
Proposed Sale
4,156$22.35$92.9K—

View →

Nov 19, 2024Nov 19 9:24 PMNEIL KUMAR
Proposed Sale
27,389$22.35$612.1K—

View →

Sep 13, 2024Sep 13 9:04 PMKKR Genetic Disorder L.P.
Proposed Sale
5,800,000$26.95$156.3M—

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 16, 2026Aug 18 10:02 PMNeil KumarDirector, Chief Executive Officer
Option Exercise
71,217—91,274(D)

View →

Jul 9, 2026Jul 13 8:41 PMAndrea EllisDirector
Option Exercise
17,167$16.7517,167(D)

View →

Jul 9, 2026Jul 13 8:40 PMJennifer E. CookDirector
Option Exercise
148,589$29.000(D)

View →

Jun 24, 2026Jun 24 10:06 PMJennifer E. CookDirector
Option Exercise
37,167$16.7517,167(D)

View →

Jun 22, 2026Jun 24 10:06 PMJennifer E. CookDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMHannah ValantineDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMHannah ValantineDirector
Option Exercise
2,808$41.735,617(D)

View →

Jun 22, 2026Jun 24 10:06 PMLo AndrewDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMCharles J HomcyDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMEric AguiarDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMDANIELS RONALD JDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMAndrea EllisDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMHassan FredDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMJames C MomtazeeDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMFrank MccormickDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMDouglas A. DachilleDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMAli J. SatvatDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 15, 2026Jun 17 8:45 PMJennifer E. CookDirector
Option Exercise
83,088$16.7534,334(D)

View →

May 16, 2026May 19 8:27 PMNeil KumarDirector, Chief Executive Officer
Option Exercise
71,215—97,794(D)

View →

May 15, 2026May 19 8:25 PMRandal W. ScottDirector
Option Exercise
10,000$16.7521,501(D)

View →

Page 1 of 2

Next →